{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T21:15:21Z","timestamp":1721423721134},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,10,15]]},"DOI":"10.2169\/internalmedicine.4822-20","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T22:05:23Z","timestamp":1592863523000},"page":"2565-2569","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent Enteritis Associated with Epstein-Barr Virus-positive CD4<sup>+<\/sup> T-cell Lymphoproliferative Disorder after Autologous Stem Cell Transplantation"],"prefix":"10.2169","volume":"59","author":[{"given":"Shinichiro","family":"Kawaguchi","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Oshiro","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Ichi","family":"Imadome","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine for Infections, National Center for Child Health and Development (NCCHD), Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127: 2375-2390, 2016;19.","DOI":"10.1182\/blood-2016-01-643569"},{"key":"2","unstructured":"2. Rajkumar SV, Harousseau JL, Durie B, et al. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood 117: 4691-4695, 2011."},{"key":"3","unstructured":"3. Al Hamed R, Bazarbachi AH, Mohty M. Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities. Bone Marrow Transplant 55: 25-39, 2020."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nash RA, Dansey R, Storek J, et al. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Biol Blood Marrow Transplant 9: 583-591, 2003.","DOI":"10.1016\/S1083-8791(03)00228-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Powell JL, Bunin NJ, Callahan C, et al. An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma. Bone Marrow Transplant 33: 651-657, 2004.","DOI":"10.1038\/sj.bmt.1704402"},{"key":"6","unstructured":"6. Herreman A, Dierickx D, Morscio J, et al. Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases. Leuk Lymphoma 54: 2190-2199, 2013."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 378: 549-562, 2018.","DOI":"10.1056\/NEJMra1702693"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ghimire P. Primary gastrointestinal lymphoma. World J Gastroenterol 17: 697-707, 2011.","DOI":"10.3748\/wjg.v17.i6.697"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Horie T, Hosoe N, Takabayashi K, et al. Endoscopic characteristics of small intestinal malignant tumors observed by balloon-assisted enteroscopy. World J Gastrointest Endosc 11: 373-382, 2019.","DOI":"10.4253\/wjge.v11.i5.373"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Roth DE, Jones A, Smith L, Lai R, Preiksaitis J, Robinson J. Severe chronic active Epstein-Barr virus infection mimicking steroid-dependent inflammatory bowel disease. Pediatr Infect Dis J 24: 261-264, 2005.","DOI":"10.1097\/01.inf.0000154335.48682.af"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhang Y, Jiang Z, Liu R, Chen H, Wang M, Cao Q. Chronic active Epstein-Barr virus associated enteritis may develop into a precancerous disease. Inflamm Bowel Dis 23: E19-E21.","DOI":"10.1097\/MIB.0000000000001092"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Liu R, Wang M, Zhang L, et al. The clinicopathologic features of chronic active Epstein-Barr virus infective enteritis. Mod Pathol 32: 387-395, 2019.","DOI":"10.1038\/s41379-018-0144-1"},{"key":"13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2002-04-1240","volume":"101","author":"K Kuzushima","year":"2003","unstructured":"13. Kuzushima K, Hayashi N, Kudoh A, et al. Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells. Blood 101: 1460-1468, 2003.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"14","unstructured":"14. Salar A, Juanpere N, Bellosillo B, et al. Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. Am J Surg Pathol 30: 1274-1280, 2006."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4822-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T03:42:31Z","timestamp":1602906151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4822-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":14,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4822-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}